John Gurley, MD
John Gurley, MD, received his medical degree from The Ohio State University, College of Medicine and Public Health in Columbus and completed a fellowship at the University of Kentucky.
He is board certified by the American Board of Internal Medicine in cardiovascular disease and interventional cardiology. Dr. Gurley conceived the Inside-Out® concept and is named inventor of related patents. Dr. Gurley is Professor of Medicine at the University of Kentucky HealthCare and Director, Structural Heart Program, of the Gill Heart & Vascular Institute at the University of Kentucky, Lexington, KY.
Gabriel Bietz, MD
Gabriel Bietz, MD, received his MD at the Royal College of Surgeons in Ireland and completed a Vascular Surgery Fellowship at the University of Kentucky, Lexington, KY.
Dr. Bietz is a Vascular Surgeon in San Antonio and has been in practice for 9 years. He completed a residency at University of Kentucky. He currently practices at Peripheral Vascular Associates and is affiliated with Metropolitan Methodist Hospital in San Antonio, Texas.
Laura Minarsch has vast experience in consulting for many of the industries’ largest cardiovascular devices manufacturers; St Jude Medical, Medtronic, Johnson and Johnson Interventional Systems, Boston Scientific to name but a few.
She has over 20 years’ experience of conducting first in human clinical trials within South America, Asia Pacific and across Europe. Ms. Minarsch has a Bachelor of Science degree and is certified by the Society of Clinical Research Associates, Cardiovascular Credentialing International and the American Registry of Radiologic Technologists.
Mark Horsey provides fractional financial advising services and assists financial model development, strategic financial planning, as well as general accounting and operations support. Mr. Horsey began his consulting practice in October of 2011.
Prior to that, Mr. Horsey was with Genzyme Corporation in San Antonio, most recently serving as Director of Finance for San Antonio Operations and Genzyme’s multiple sclerosis business unit.
Prior to joining Genzyme, Mr. Horsey was Business Unit Controller for Dell Computer in Round Rock, Texas. Mr. Horsey received his undergraduate degree in economics from the University of Texas at Austin, and an M.B.A. from Saint Edward’s University with a specialization in finance. Mr. Horsey has also recently completed a Financial Planning Certificate program through Northwestern University’s Kellogg School of Management.
With over 30 years of combined experience for domestic and international medical device, pharmaceutical, and molecular diagnostic companies, Larry Yost offers entrepreneurial and large company clients the expertise required for a wide range of their strategic market development and tactical marketing needs.
Prior to founding The Atticus Group, Larry was the Vice-President of Sales and Marketing at Expanding Orthopedics, Inc., a start-up medical device company focused on the development of innovative spinal implant for patients with poor bone quality and novel solutions for fracture repair in orthopedic trauma patients.
Previously, Larry was Director of Marketing at Salient Surgical Technologies (formerly TissueLink Medical and now Medtronic Advanced Energy), an early stage company with a proprietary radiofrequency technology used to reduce blood loss during total joint replacement, spine surgery, and solid organ resection. Before joining Salient, Larry was Director of Marketing at Vasca, Inc., a start-up medical device company with innovative implantable dialysis-access technology. Prior to his time at Vasca, Larry was a member of the global marketing team at Baxter Healthcare’s Renal Division where his focus was the development of clinical marketing programs supporting the company’s dialysis product lines in the U.S., Japan, Asia, and Europe. Larry began his career in pharmaceutical sales at The Upjohn Company followed by several differing roles within the Company’s Medical Sciences Liaison organization.
Larry is a graduate of the Purdue University School of Pharmacy and currently maintains his Pharmacist license in the State of Indiana.
Katie Arnold is a strategic marketing professional with 20 years of healthcare experience. Katie has worked with medical technology companies ranging from venture-backed start-ups to Fortune 500 companies.
Throughout her career, she has focused on the entire spectrum of commercialization needs: from upstream market development strategy to downstream product launch execution.
Katie founded SPRIG in 2008 in Silicon Valley in response to the emerging needs of early-stage medical technology start-ups to navigate company development with limited resources and strict financial constraints. Since SPRIG’s inception, Katie and her team have produced clear, measurable results for an exciting roster of clients. The team has experience across a broad range of therapeutic spaces and offers a variety of services including business and clinical development, marketing and reimbursement strategies.
Prior to founding SPRIG, Katie had a successful career with Guidant Corporation (acquired) and Kensey Nash Corporation (acquired) launching novel technologies. Katie holds an MBA from Northwestern University’s Kellogg Graduate School of Management where she was awarded the Health Industry Management Scholarship. Katie is also a Kellogg lecturer and teaches a graduate-level course on medical product commercialization. Katie holds a BA from the University of Vermont.
Brian Young is a senior regulatory, quality, and clinical professional with thirty years of diversified work experience in the medical device and diagnostic industry.
His experience comprises a broad range of clinical and therapeutic areas, including orthopedics, wound care, in vitro diagnostics, general surgery, and cardiovascular surgery. His experience includes work with cardiovascular stents, catheters, human tissue (dermis and bone), animal tissue, drug-device combination products, electromechanical and wound care devices, in vitro diagnostic analyzers, assays, reagents, electrodes, and accessories.
Mr. Young’s extensive face-to-face experience with the FDA includes hundreds of submissions for Class II and Class III devices. He has developed quality systems from the ground up and has led inspections and audits with FDA, Canada, Europe, Australia and state health organizations. His international experience includes obtaining the first approval for a new technology category in Japan and a first foreign approval for a new technology category in China.
Mr. Young’s has published articles in Regulatory Affairs Focus and authored a chapter in the 2016 Global Medical Device Regulatory Strategy Textbook. He has led successful efforts to bring new and highly differentiated products to the US, Canada, Europe, Japan, India, China, Japan and Brazil.
He received his Bachelor of Science in Medical Technology from the University of Iowa and his Master’s in Business Administration from Duke University’s Fuqua School of Business.